12 results · 20ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

SPIROBANK II

FDA 510(k)
FDA Class 2 ·Anesthesiology

FITLIFE

FDA UDI
Respironics, Inc.·00606959023062·FitLife Mask with Headgear, with Standard Elbow...

Epimed

FDA UDI
EPIMED INTERNATIONAL, INC·00818788020321·RX Epidural Needle 12g TW x 7.0"

LATEX EXAMINATION GLOVES- POWDER FREE, BLUE

FDA 510(k)
FDA Class 1 ·General Hospital

3D ACTIVETRAC

FDA 510(k)
FDA Class 2 ·Physical Medicine

LIFEVEST WCD 4000 SYSTEM

FDA Adverse Event
Malfunction ·ZOLL LIFECOR CORPORATION·Product code MVK·March 29, 2013

BUBBLE CPAP CIRCUIT

FDA Adverse Event
Malfunction ·FISHER & PAYKEL HEALTHCARE LIMITED·Product code BZD·April 19, 2011

SEPRAFILM (SODIUM HYALURONATE, CARBOXYMETHYLCELLULOSE) MEMBRANE

FDA Adverse Event
Other ·GENZYME BIOSURGERY (SEPRAFILM/PACK)·Product code MCN·June 17, 2008

BD VACUTAINER® LITHIUM HEPARINN (LH) 158 USP UNITS BLOOD COLLECTION TUBES

FDA Adverse Event
Malfunction ·BECTON, DICKINSON & CO. (BROKEN BOW)·Product code JKA·June 24, 2019

Ultra/Phonic Focus BP Conforming Gel Pads, UDI 00300361301021 (Primary); 10300361301028 (Package) - Product Usage: A gel pad for use on woman s areola during an ultrasound examination. Its primary purpose is for patient comfort over the loose gel and helps with nipple location during the scan, making the areola location easier to identify.

FDA Enforcement
Class II ·Terminated·Pharmaceutical Innovations, Inc.·August 26, 2020

CADD¿- Solis Ambulatory Infusion Pump, Model 2111 & 2112, Version 1.0, Version 2.0 and Version 3.0 & Model 2120, Version 1.0. Provide measured drug therapy to patients in hospital or outpatient settings.

FDA Enforcement
Class II ·Terminated·Smiths Medical ASD, Inc.·June 24, 2015

CADD-Solis VIP ambulatory Infusion Pumps, Model 2120 (21-2120, 21-2125, and 21-2127) Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024